Thailand announces AIDS vaccine `breakthrough’
September 24th, 2009 - 2:46 pm ICT by IANSBangkok, Sep 24 (DPA) Thai health authorities Thursday announced the first “effective” trial of an HIV/AIDS vaccine on some 16,000 volunteers.
“It is found that the vaccine has 31.2 percent efficacy in reducing the risk of HIV infection,” Thai Health Minister Withaya Kaewparadai told a press conference.
“The outcome represents a breakthrough in HIV vaccine development because for the first time ever there is evidence that HIV vaccine has preventative efficacy,” he added.
The results were part of the HIV Vaccine Trial Phase III in Chonburi and Rayong provinces.
The trial, deemed the world’s largest HIV vaccine study, was sponsored by the US Army Surgeon General with funding from the National Institute of Health and the US Army Medical Research.
Thailand has an estimated 600,000 people who are living with HIV/AIDS.
- Thailand announces AIDS vaccine 'breakthrough' (Lead) - Sep 24, 2009
- An AIDS Vaccine is Possible - May 18, 2010
- State of the ART of microbicides to prevent HIV - May 24, 2010
- Russia tests HIV vaccine - Feb 06, 2012
- 28,000 die of HIV/AIDS in China - Jan 22, 2012
- UN meet delegates says funds for HIV/AIDS control inadequate - Jun 11, 2011
- 12 dead in Thailand factory blast - May 06, 2012
- Aim to eliminate HIV-AIDS from South-East Asia by 2015: WHO (Dec 1 is World AIDS Day) - Nov 30, 2011
- Delhi to launch AIDS awareness campaign - Sep 20, 2011
- Alarming HIV/AIDS surge among Pakistan's drug addicts - Jan 23, 2012
- New vaccine could prevent TB in patients with HIV infection - Jan 30, 2010
- Scriptures to help fight HIV-AIDS - Mar 12, 2011
- Aid appeal to combat HIV/AIDS in Myanmar - Dec 06, 2011
- 'Funds needed urgently to capitalise on HIV breakthroughs' - Jul 24, 2011
- 37 Bangladeshis died due to AIDS in 2010 - Dec 01, 2010
Tags: aids vaccine, army medical research, army surgeon general, chonburi, efficacy, health authorities, health minister, hiv aids, hiv infection, hiv vaccine development, hiv vaccine study, hiv vaccine trial, institute of health, living with hiv, national institute of health, phase iii, rayong, risk of hiv, trial phase, us army